T-Cell COVID-19 Vaccine Offers Longer Protection Than Current Vaccines miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
The current COVID-19 vaccines are designed to trigger an antibody response to the SARS-CoV-2 spike protein, which is vulnerable to mutations that could make the vaccine less effective over time. Focusing on the T-cell instead, Penn State researchers partnered with Evaxion Biotech on a study that was the first to demonstrate the effectiveness of an artificial intelligence-generated vaccine in a live viral challenge model. Such a vaccine may provide long-lasting immunity against future emerging variants and could be used as a model for other seasonal viral diseases like the flu.
Mabanaft and Hapag-Lloyd have signed a Memorandum of Understanding (MoU) to evaluate options for the supply of ammonia as bunker fuel to the container transport company in and around the ports of Hamburg and Houston.
Founded in the US, industrial water management company Pentair is also considered to be one of world’s leading carbon dioxide (CO2) technology companies for generation, recovery and purification & liquefaction of high quality CO2. Having.